OOIR: Observatory of International Research

Papers

(The TQCC of European Journal of Contraception and Reproductive Health Care is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
A pioneer of hormonal contraception: Joseph W. Goldzieher	161
Modern contraceptive use among women of reproductive age in Zimbabwe: analysis of 1999–2015 Zimbabwe Demographic Health Survey	49
Correction	23
Statement of Retraction [Post-placental intrauterine device insertion vs puerperal insertion in women undergoing caesarean delivery in Egypt: a 1 year randomised controlled trial]	20
Family planning and contraception in women of reproductive age with systemic lupus erythematosus: a narrative review	16
Hypertension and smoking as contraindications to combined hormonal contraception but not to postmenopausal hormone therapy: but natural oestrogens (oestradiol and estetrol) are the same!	15
How often is oral contraception used for contraception? The need of benefit’s formalisation	15
Patient acceptability of intra-amniotic digoxin versus intracardiac lidocaine for inducing foetal demise prior to second trimester medical abortion: a prospective cohort	15
The prolonged-release oral formulations: a new era in hormonal contraception technology?	13
Investigating barriers to effective contraceptive use in Sub-Saharan Africa and addressing associated challenges	13
Measurement of pain during first trimester medical abortion: an exploratory qualitative study	13
Effect of antenatal contraceptive education and other factors on uptake of long-acting reversible contraception in postpartum women in Hong Kong	12
Knowledge of contraceptive methods among deaf women: a qualitative study	11
Improving access to postpartum contraception – a review of global guidelines with ESCRH consensus recommendations for Europe	11
Perception of oral contraception – do women think differently from gynaecologists?	9
Contraceptive switch and abandonment among women using the pill, condoms and injectables in Brazil	9
A titrated low-dose misoprostol protocol for second-trimester abortion (13–26 weeks) in women with one prior cesarean and preterm premature rupture of membranes: a clinical practice report	9
The far-reaching impact of abortion bans: reproductive care and beyond	9
Factors affecting age at menopause and their relationship with ovarian reserve: a comprehensive review	8
Asked but not received: postpartum contraception access in opioid-using pregnant patients	7
Statement of Retraction [Can Porphyromonas gingivalis be a novel aetiology for recurrent miscarriage?]	7
Improvement of laboratory markers of anaemia in the treatment of heavy menstrual bleeding with a 19.5-mg intrauterine device: a pilot study	7
Clinical and histopathological correlations in symptomatic patients with salpingectomy for Essure ^® implant removal: a cross-sectional study	7
Evaluating the fidelity of AI-generated information on long-acting reversible contraceptive methods	6
Statement of Retraction [Ultrasound-guided versus uterine sound-sparing approach during copper intrauterine device insertion: a randomised clinical trial]	6

The criminalisation of women’s healthcare in the post-Dobbs era: an analysis of the anti-abortion trigger law statutes	6
Women’s decision-making related to induced abortion – a cross sectional study during a period of Covid-19 pandemic, in Sweden	6
Sequential treatment with relugolix combination therapy in women with symptomatic uterine fibroids that were inadequately managed with 52 mg levonorgestrel intrauterine system: the first report	6
The pre- Roe legal framework: a dissecting study of the evolution of abortion laws and their socio-legal implications	5
Increasing access to immediate postpartum contraceptive implants: a prospective clinical trial among patients with opioid use disorder	5
Advancing access, evidence, and equity in abortion care	5
“Better late than never but never late is better”, especially in young women. A multicenter Italian study on diagnostic delay for symptomatic endometriosis	5
Experiences and impacts of side effects among contraceptive users in the UK: exploring individual narratives of contraceptive side effects	5
Optimising contraceptive counselling: insights for obesity and bariatric surgery patients	5
The love-shaper: role of the foetus in modulating mother-child attachment through stem cell migration to the maternal brain	5
Narratives of men and women from the southeastern region of Brazil on some aspects of sexual and reproductive health, sexual life and contraception: a qualitative study	5
Access to abortion in a cross-border region in the Eastern Pyrenees: the case of Hospital de Cerdanya, between Spanish and French legislation	4
Clinical improvement after Essure® devices removal: a systematic review	4
Impact of abortion bans on pregnancies with severe life-limiting foetal anomalies in the United States: a cost-effectiveness analysis	4
Acceptance rate of post-placental plac ement of intrauterine devices during the SARS-CoV-2 (COVID-19) pandemic	4
Beyond dietary habits: ultra-processed food consumption reveals the association with HPV infection in U.S. women	4
Retraction Notice	4
Retraction	4
Pharmacist recommendations for emergency contraception in Belgium: a simulated user study	4
Women's perspectives on impact on the post menopause of use of the 52 mg levonorgestrel intrauterine device during the menopausal transition	4
Contraception for adolescent and young women. A consensus conference results	4
Assessing the impact of hormonal contraceptive use on menstrual health among women of reproductive age – a systematic review	4
A pilot randomised study to compare sub-lingual and vaginal routes of low-dose misoprostol following two sequential doses of mifepristone for second-trimester medical abortion	4
We don´t have elements to scare women who use oral contraceptives based on nomegestrol or chlormadinone about the risk of meningioma. Let's be careful and honest!	4
Use of etonogestrel subcutaneous implant in Sardinia, Italy: women’s compliance and satisfaction	4
The impact of using the levonorgestrel-releasing intrauterine device on the incidence of acne in adolescents and young women	4
Ulipristal acetate for medical abortion: did we really need to create a ‘monster’?	4
Correlation of sexual desire with sexual hormone binding globulin and free androgen index in women using combined contraceptives	4
Does change in the shape of intrauterine contraceptive device Cu 375 and Cu T 380A affect the expulsion after post-partum insertion – a prospective randomized control trial	4
Knowledge, attitudes, and perceptions of health care providers regarding the recommendation and use of long-acting reversible contraceptive devices for adolescent patients	3
Comments on: ‘Critical assessment of a prolonged-release EE/DNG contraceptive safety analysis’ - a letter to the editor to the European Jornal of Contraception by Jonathan Douxfils et al	3
Can transvaginal cervical length and cervical strain elastography predict mid-trimester medical induction to abortion intervals?	3
Usage of postpartum intrauterine contraceptive device (postpartum-IUD) after an increase in the institutional delivery rate in India: time to re-visit the effect of timing of counselling on its accept	3
Correction	3
Authors response to article retraction	3
Editors’ response	3
High-intensity focussed ultrasound and hysteroscopy endo-operative system cold device procedures for treating >4cm diameter FIGO Type 2 uterine myoma and ensuring successful pregnancy	3
Menstrual cycle abnormalities in women: characteristics, perceptions, and health-seeking behaviours	3
Legal abortion requests and outcomes for women when the law is restrictive – experience from a referral centre in south-eastern Brazil	3
Depomedroxyprogesterone acetate impact on mifepristone action during medication abortion	3
Medical termination of pregnancy: people’s expectations and experiences in the Netherlands	3
The role of progestin subdermal implant in the management of adenomyosis: a systematic review	3
First report of linzagolix as bridge therapy for progesterone hypersensitivity, an ultra-rare disorder	3
The role of combined oral contraceptives containing norgestimate for acne vulgaris treatment: a review	3
Real-world satisfaction and menstrual bleeding pattern with available LNG-IUD among Spanish young women	3
From hesitancy to hope: charting India’s path to widespread HPV immunisation	3
Onset and recovery from depressive mood changes on progestin treatment - a case series reporting the course and type of depressive symptoms in progestin users with different histories and risks	3
Expression of Concern	3
Fertility awareness, reproductive autonomy and what people should know about having children	3
‘Do I want children later in life?’ Reproductive intentions of 1700 adolescents	3

Statement of Retraction [Current contraceptive trends among married Egyptian women: a cross-sectional survey]	3
Expression of concern: Evaluation of knowledge and practice of hymenoplasty among Egyptian gynaecologists: a cross-sectional study	3
Intrauterine devices and gynaecological malignancies - an umbrella review of systematic reviews and meta-analyses	3